Annual Short Term Debt
$1.20 M
+$100.00 K+9.12%
31 December 2023
Summary:
Compass Therapeutics annual short term debt is currently $1.20 million, with the most recent change of +$100.00 thousand (+9.12%) on 31 December 2023. During the last 3 years, it has fallen by -$6.27 million (-83.97%). CMPX annual short term debt is now -83.97% below its all-time high of $7.47 million, reached on 01 December 2020.CMPX Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Short Term Debt
$557.00 K
-$531.00 K-48.81%
01 September 2024
Summary:
Compass Therapeutics quarterly short term debt is currently $557.00 thousand, with the most recent change of -$531.00 thousand (-48.81%) on 01 September 2024. Over the past year, it has dropped by -$617.00 thousand (-52.56%). CMPX quarterly short term debt is now -93.45% below its all-time high of $8.50 million, reached on 01 March 2021.CMPX Quarterly Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CMPX Short Term Debt Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +9.1% | -52.6% |
| 3 y3 years | -84.0% | -88.4% |
| 5 y5 years | -67.5% | - |
CMPX Short Term Debt High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -84.0% | +21.0% | -88.4% | at low |
| 5 y | 5 years | -84.0% | +21.0% | -93.5% | at low |
| alltime | all time | -84.0% | +21.0% | -93.5% | at low |
Compass Therapeutics Short Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $557.00 K(-48.8%) |
| June 2024 | - | $1.09 M(-11.1%) |
| Mar 2024 | - | $1.22 M(+2.3%) |
| Dec 2023 | $1.20 M(+9.1%) | $1.20 M(+2.0%) |
| Sept 2023 | - | $1.17 M(+2.4%) |
| June 2023 | - | $1.15 M(+2.2%) |
| Mar 2023 | - | $1.12 M(+2.3%) |
| Dec 2022 | $1.10 M | $1.10 M(+2.0%) |
| Sept 2022 | - | $1.07 M(+2.3%) |
| June 2022 | - | $1.05 M(+2.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $1.03 M(+3.8%) |
| Dec 2021 | $989.00 K(-86.8%) | - |
| Dec 2021 | - | $989.00 K(-79.5%) |
| Sept 2021 | - | $4.82 M(-27.7%) |
| June 2021 | - | $6.66 M(-21.6%) |
| Mar 2021 | - | $8.50 M(+13.8%) |
| Dec 2020 | $7.47 M(+33.9%) | $7.47 M(+0.1%) |
| Sept 2020 | - | $7.46 M(+0.1%) |
| June 2020 | - | $7.45 M(+33.7%) |
| Dec 2019 | $5.58 M(+51.2%) | $5.58 M |
| Dec 2018 | $3.69 M | - |
FAQ
- What is Compass Therapeutics annual short term debt?
- What is the all time high annual short term debt for Compass Therapeutics?
- What is Compass Therapeutics annual short term debt year-on-year change?
- What is Compass Therapeutics quarterly short term debt?
- What is the all time high quarterly short term debt for Compass Therapeutics?
- What is Compass Therapeutics quarterly short term debt year-on-year change?
What is Compass Therapeutics annual short term debt?
The current annual short term debt of CMPX is $1.20 M
What is the all time high annual short term debt for Compass Therapeutics?
Compass Therapeutics all-time high annual short term debt is $7.47 M
What is Compass Therapeutics annual short term debt year-on-year change?
Over the past year, CMPX annual short term debt has changed by +$100.00 K (+9.12%)
What is Compass Therapeutics quarterly short term debt?
The current quarterly short term debt of CMPX is $557.00 K
What is the all time high quarterly short term debt for Compass Therapeutics?
Compass Therapeutics all-time high quarterly short term debt is $8.50 M
What is Compass Therapeutics quarterly short term debt year-on-year change?
Over the past year, CMPX quarterly short term debt has changed by -$617.00 K (-52.56%)